조직 공학용 3D 바이오프린팅 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 재료 유형, 프로세스, 최종 사용자, 기능

The global 3D Bioprinting for Tissue Engineering Market is projected to grow from $1.4 billion in 2025 to $4.9 billion by 2035, at a compound annual growth rate (CAGR) of 13.3%. The 3D Bioprinting for Tissue Engineering Market is driven by growing demand for regenerative medicine, increasing research into engineered tissues, and advances in biomaterials and bioprinting technologies. According to the NIH, 3D bioprinting enables researchers to combine living cells with scaffolding materials to create complex three-dimensional tissue models. Advances in bioinks, stem cells, extrusion-based printing, laser-assisted techniques, and biomaterial engineering are enabling the development of customized tissue constructs for bone, cartilage, skin, and other applications. The FDA also identifies 3D-printed scaffolds with cells as an emerging regenerative medicine approach, supporting continued research and development.

The Type segment of the 3D Bioprinting for Tissue Engineering Market includes Extrusion-based, Inkjet-based, Laser-based, Microvalve-based, and Others. Extrusion-based bioprinting held the largest share in 2025, supported by its ability to print a wide range of biomaterials and cell-laden bioinks, scalability, and suitability for producing complex tissue scaffolds. Laser-based bioprinting is expected to be the fastest-growing segment, driven by its high printing precision, controlled cell placement, and increasing use in advanced tissue engineering and regenerative medicine. Inkjet-based and Microvalve-based technologies remain important for precise deposition of cells and biomaterials, while Others include emerging bioprinting approaches.

The Application segment of the 3D Bioprinting for Tissue Engineering Market includes Tissue Engineering, Drug Testing and Development, Regenerative Medicine, Research, and Others. Tissue Engineering held the largest share in 2025, driven by increasing use of 3D bioprinting to develop biomimetic scaffolds, tissue constructs, and cell-based models for repairing or replacing damaged tissues. Regenerative Medicine is expected to be the fastest-growing segment, supported by advances in cell-based therapies, personalized medicine, organ and tissue fabrication, and bioprinted implant development. Drug Testing and Development is increasingly adopting bioprinted tissue models to improve drug screening, while Research applications continue to support technological development and validation.

Geographical Overview

North America held the largest share of the 3D Bioprinting for Tissue Engineering Market in 2025. The regions leadership is supported by advanced biotechnology and healthcare infrastructure, substantial research funding, and strong collaboration among universities, biotechnology companies, pharmaceutical firms, and medical institutions. The U.S. remains the primary contributor, with growing investments in regenerative medicine, tissue engineering, drug development, and bioprinted tissue research. Increasing clinical research into engineered tissues, alongside advances in bioinks, extrusion and light-based printing technologies, is strengthening commercial opportunities. Regulatory progress and rising investments in personalized and regenerative therapies are also supporting North America's dominant position.

Asia Pacific is expected to be the fastest-growing region in the 3D Bioprinting for Tissue Engineering Market during the forecast period. The region's expansion is supported by increasing healthcare and biotechnology investments, government initiatives for regenerative medicine, and growing research activity in China, Japan, South Korea, and India. Rising demand for advanced tissue-engineering solutions, organ-model development, and personalized medicine is encouraging universities, pharmaceutical companies, and biotechnology firms to adopt bioprinting technologies. Japan and China are strengthening capabilities in biofabrication, biomaterials, and regenerative medicine, while improving healthcare infrastructure is expanding opportunities for clinical applications. Asia Pacific is projected to register the highest regional growth rate through the forecast period.

Key Trends and Drivers

Increasing Development of Patient-Specific Tissue Constructs:

A key trend in the 3D bioprinting for tissue engineering market is the increasing development of patient-specific tissue constructs using advanced bioprinting technologies. Researchers and biotechnology companies are combining 3D bioprinters with biomaterials, bioinks, stem cells, and digital imaging to create tissue structures with controlled geometries and biological characteristics. Advances in extrusion, inkjet, and laser-assisted bioprinting are improving the ability to deposit cells and biomaterials with greater spatial precision. This trend is supporting the development of engineered skin, cartilage, bone, vascular structures, and other tissues while increasing interest in personalized regenerative medicine and laboratory models that better replicate human tissue characteristics.

Growing Demand for Regenerative Medicine and Tissue Replacement:

A key driver of the 3D bioprinting for tissue engineering market is the growing demand for regenerative medicine solutions capable of repairing or replacing damaged tissues and organs. Conventional tissue grafting and organ transplantation face challenges including donor shortages, tissue compatibility, and limited availability of suitable biological materials. 3D bioprinting offers an alternative approach by enabling the fabrication of structured biological constructs using living cells and biomaterials. Increasing research into stem-cell technologies, biomaterials, tissue regeneration, and organ fabrication is encouraging investment in bioprinting platforms. Growing efforts to address unmet needs in tissue repair and develop functional biological substitutes are therefore supporting market expansion.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by Material Type
• 2.8 Key Market Highlights by End User
• 2.9 Key Market Highlights by Process
• 2.10 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Extrusion-based
  • 4.1.2 Inkjet-based
  • 4.1.3 Laser-based
  • 4.1.4 Microvalve-based
  • 4.1.5 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 3D Bioprinters
  • 4.2.2 Biomaterials
  • 4.2.3 Scaffolds
  • 4.2.4 Software
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Custom Prototype Development
  • 4.3.2 Consulting
  • 4.3.3 Maintenance
  • 4.3.4 Training
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Magnetic Levitation
  • 4.4.2 Stereolithography
  • 4.4.3 Digital Light Processing
  • 4.4.4 Fused Deposition Modeling
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Hardware
  • 4.5.2 Software
  • 4.5.3 Biomaterials
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Tissue Engineering
  • 4.6.2 Drug Testing and Development
  • 4.6.3 Regenerative Medicine
  • 4.6.4 Research
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Material Type (2020-2035)
  • 4.7.1 Hydrogels
  • 4.7.2 Living Cells
  • 4.7.3 Extracellular Matrices
  • 4.7.4 Synthetic Polymers
  • 4.7.5 Others
• 4.8 Market Size & Forecast by End User (2020-2035)
  • 4.8.1 Research Organizations
  • 4.8.2 Biopharmaceutical Companies
  • 4.8.3 Hospitals
  • 4.8.4 Academic Institutes
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Process (2020-2035)
  • 4.9.1 Pre-processing
  • 4.9.2 Processing
  • 4.9.3 Post-processing
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Functionality (2020-2035)
  • 4.10.1 Cell Printing
  • 4.10.2 Scaffold Printing
  • 4.10.3 Organ Printing
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 Material Type
    • 5.2.1.8 End User
    • 5.2.1.9 Process
    • 5.2.1.10 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 Material Type
    • 5.2.2.8 End User
    • 5.2.2.9 Process
    • 5.2.2.10 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 Material Type
    • 5.2.3.8 End User
    • 5.2.3.9 Process
    • 5.2.3.10 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 Material Type
    • 5.3.1.8 End User
    • 5.3.1.9 Process
    • 5.3.1.10 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 Material Type
    • 5.3.2.8 End User
    • 5.3.2.9 Process
    • 5.3.2.10 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 Material Type
    • 5.3.3.8 End User
    • 5.3.3.9 Process
    • 5.3.3.10 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 Material Type
    • 5.4.1.8 End User
    • 5.4.1.9 Process
    • 5.4.1.10 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 Material Type
    • 5.4.2.8 End User
    • 5.4.2.9 Process
    • 5.4.2.10 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 Material Type
    • 5.4.3.8 End User
    • 5.4.3.9 Process
    • 5.4.3.10 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 Material Type
    • 5.4.4.8 End User
    • 5.4.4.9 Process
    • 5.4.4.10 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 Material Type
    • 5.4.5.8 End User
    • 5.4.5.9 Process
    • 5.4.5.10 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 Material Type
    • 5.4.6.8 End User
    • 5.4.6.9 Process
    • 5.4.6.10 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 Material Type
    • 5.4.7.8 End User
    • 5.4.7.9 Process
    • 5.4.7.10 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 Material Type
    • 5.5.1.8 End User
    • 5.5.1.9 Process
    • 5.5.1.10 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 Material Type
    • 5.5.2.8 End User
    • 5.5.2.9 Process
    • 5.5.2.10 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 Material Type
    • 5.5.3.8 End User
    • 5.5.3.9 Process
    • 5.5.3.10 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 Material Type
    • 5.5.4.8 End User
    • 5.5.4.9 Process
    • 5.5.4.10 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 Material Type
    • 5.5.5.8 End User
    • 5.5.5.9 Process
    • 5.5.5.10 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 Material Type
    • 5.5.6.8 End User
    • 5.5.6.9 Process
    • 5.5.6.10 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 Material Type
    • 5.6.1.8 End User
    • 5.6.1.9 Process
    • 5.6.1.10 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 Material Type
    • 5.6.2.8 End User
    • 5.6.2.9 Process
    • 5.6.2.10 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 Material Type
    • 5.6.3.8 End User
    • 5.6.3.9 Process
    • 5.6.3.10 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 Material Type
    • 5.6.4.8 End User
    • 5.6.4.9 Process
    • 5.6.4.10 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 Material Type
    • 5.6.5.8 End User
    • 5.6.5.9 Process
    • 5.6.5.10 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Organovo Holdings
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 CELLINK
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Allevi
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Aspect Biosystems
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 3D Systems
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 RegenHU
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 EnvisionTEC
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Cyfuse Biomedical
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Poietis
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Biogelx
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Advanced Solutions Life Sciences
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Pandorum Technologies
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Prellis Biologics
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Nano3D Biosciences
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Rokit Healthcare
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 MatTek Corporation
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 TeVido BioDevices
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 CollPlant Biotechnologies
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 VIVAX BIO
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Bioprinting Solutions
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us